The impact of indacaterol/glycopyrronium fixed-dose combination versus tiotropium monotherapy on lung function and treatment preference: a randomized crossover study – the FAVOR study

Autor:	Kardos P, Hagedorn-Peinz I
Jazyk:	angličtina
Rok vydání:	2017
Předmět:	COPD dual-bronchodilators FEV1 indacaterol/glycopyrronium treatment preference treatment satisfaction Diseases of the respiratory system RC705-779
Zdroj:	International Journal of COPD, Vol Volume 13, Pp 69-77 (2017)
Druh dokumentu:	article
ISSN:	1178-2005
Popis:	Peter Kardos,1 Ina Hagedorn-Peinz2 1Pulmonary Department, Respiratory and Sleep Medicine at Red Cross Maingau Hospital, Group Practice Allergy, Frankfurt, Germany; 2Novartis Pharma GmbH, Nuremberg, Germany Background: The objective of the FAVOR study was to evaluate the effect of indacaterol/glycopyrronium (IND/GLY) versus tiotropium on peak forced expiratory volume in 1 s (FEV1) and also to investigate patient satisfaction and treatment preference. Methods: Patients with moderate-to-severe airflow limitation (FEV1/forced vital capacity ratio of
Databáze:	Directory of Open Access Journals
Externí odkaz:	https://doaj.org/article/e456c19b3d1a42e78d7829f9bbb6bf08 Zobrazit plný text záznamu View record in DOAJ